<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eleven patients with high-grade mucosal <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in a <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined oesophagus</z:e> and 2 patients with a squamous <z:mp ids='MP_0002038'>carcinoma</z:mp> (uT1) underwent photodynamic therapy (<z:chebi fb="7" ids="53228">PDT</z:chebi>) and <z:chebi fb="17" ids="49474,49475">argon</z:chebi>-plasma coagulation (APC) </plain></SENT>
<SENT sid="1" pm="."><plain>For <z:chebi fb="7" ids="53228">PDT</z:chebi>, <z:chebi fb="0" ids="17549">5-aminolevulinic acid</z:chebi> (5-ALA) was given orally (60 mg/kg) and treated endoscopically with a light dose of 150 J/cm2 (100 mW/cm2) at 635 nm 4-6 h later </plain></SENT>
<SENT sid="2" pm="."><plain>A second <z:chebi fb="7" ids="53228">PDT</z:chebi> was performed under the same conditions 2-3 weeks later </plain></SENT>
<SENT sid="3" pm="."><plain>Patients who received APC were treated 4 times on average to reach radical Barrett mucosa eradication </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were consistently given medication to suppress acid production </plain></SENT>
<SENT sid="5" pm="."><plain>No complications occurred in either group </plain></SENT>
<SENT sid="6" pm="."><plain>Follow-up endoscopies and multiple biopsies for 3-42 months showed squamous regeneration in the dysplastic <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined oesophagus</z:e> in <z:hpo ids='HP_0000001'>all</z:hpo> 11 patients </plain></SENT>
<SENT sid="7" pm="."><plain>Two patients with squamous <z:mp ids='MP_0002038'>carcinoma</z:mp> were found to have a recurrence 9 and 12 months later </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="7" ids="53228">PDT</z:chebi> with 5-ALA-induced endogenous prophyrins, as well as APC combined with <z:chebi fb="14" ids="7772">omeprazole</z:chebi> protection, can eradicate superficial high-grade dysplastic mucosa in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>However, we did not succeed in destroying a manifest <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
</text></document>